Atlas Trials

A Multicentre Randomized Controlled Clinical Study on the Chitosan Nanocrystalline Qinteng Huoxue Runji Ointment Therapy for Psoriasis With Blood Stasis Syndrome.

Clinical trial NCT06396013 · UNKNOWN

Trial details

NCT number
NCT06396013
Sponsor
Beijing Hospital of Traditional Chinese Medicine
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Plaque Psoriasis
Start date
2024-06-01
Primary completion
2026-06-01
Enrollment
96

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.